NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Strip, Model No. 300900
FDA Device Recall #Z-1251-2022 — Class II — May 13, 2022
Recall Summary
| Recall Number | Z-1251-2022 |
| Classification | Class II — Moderate risk |
| Date Initiated | May 13, 2022 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | NeuMoDx Molecular Inc |
| Location | Ann Arbor, MI |
| Product Type | Devices |
| Quantity | 459 kits US; 1626 kits OUS |
Product Description
NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Strip, Model No. 300900
Reason for Recall
There is a potential for reduced analytical sensitivity for samples in the 1x - 3x LOD range for Flu A, RSV, and SARS-CoV-2 targets. This may lead to false negative results, allowing ongoing transmission to others and delaying appropriate treatment.
Distribution Pattern
Domestic distribution to FL, NY, MD, PA, VA, MI, TN, NM. Foreign distribution to AT, AU, BE, CH, DE, FI, FR, GB, GR, HK, ID, IT, LT, NL, SA, SE, and SI.
Lot / Code Information
UDI-DI (GTIN): 10814278020830 Cartridge lot numbers 111915 - 117508
Other Recalls from NeuMoDx Molecular Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2255-2023 | Class II | NeuMoDx Cartridge-used for extraction, purifica... | May 24, 2023 |
| Z-2093-2023 | Class III | NeuMoDx SARS-CoV-2 Assay -IVD intended for the... | May 15, 2023 |
| Z-1000-2022 | Class II | NeuMoDx Cartridge-For in vitro diagnostic use w... | Feb 18, 2022 |
| Z-0738-2022 | Class II | NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Str... | Jan 21, 2022 |
| Z-1978-2021 | Class II | NeuMoDx Cartridge, For In Vitro Diagnostic Use ... | May 4, 2021 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.